Navigation Links
Researchers Developing Office-Based Cancer Screening Test

Patients go to see their doctors for answers, but when it comes to cancer, physicians admit they need better tests to detect the earliest cancers. While certain tests can indicate the possibility of prostate cancer or cervical cancer,// a simple office-based test to monitor patients for cancer currently is not available to doctors and their patients.

Researchers at the University of Virginia School of Medicine are out to change that, thanks to a five-year, $1.5 million grant from the National Cancer Institute (NCI). The grant will go towards identifying proteins in human urine, known as biomarkers. The presence of specific biomarkers could indicate the presence of cancer or other diseases.

'In five years, I want a patient to visit their doctor, give a urine sample, and for the physician to put a dipstick in the sample and be able to tell their patient either 'There's no sign of cancer this year’ or 'Hmm, we'll have to find out what’s going on here’,' says Dennis Templeton, M.D., Ph.D., chairman of the Department of Pathology at the University of Virginia, where most clinical lab tests at UVa Medical Center are performed.

Templeton's grant from the NCI’s Clinical Proteomic Technologies Initiative for Cancer, will be used to support the biomarker discovery program in the UVa Pathology Department. The biomarker discovery program aims to develop new cancer tests through the use of technological discoveries that enable automated measurements of proteins in complex biological samples like urine. The UVa program uses new chemical methods and software written by team members, called PICquant, to process complex data that until now required lengthy analysis by hand.

Templeton says that the NCI understood other unique advantages at UVa. This includes easy coordination of data between the clinical labs and a database of clinical outcomes, called the clinical data repository (CDR). 'Our program is highly integrated. We are able to collect, process, and analyze sample data in automated ways that are uncommon at most medical centers, owing to this cooperation between Departments,' Templeton says.

It's the rapid processing of data which Templeton hopes will allow new tests to be brought to physicians to help catch a cancer early, when it offers the best chance for cure. 'People with cancer often don't know they have it until the cancer has metastasized. That makes treatment more complex and decreases a patient's chance at surviving. We want to swing those odds more in the patient’s favor.'

Source-Newswise'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: